Avanos Medical Bolsters Device Portfolio With Nexus Medical
On September 15, Avanos Medical, Inc. announced the acquisition of Nexus Medical, LLC for an undisclosed price. Nexus Medical is a Lenexa, Kansas-based company that develops and sells medical devices and related services globally. Its operating and reportable segment provides medical device products to healthcare providers and patients. Nexus is renowned for its TKO anti-reflux needleless connector technology, which enhances the safety and consistency of nutrition and medication delivery, particularly in high-acuity settings like neonatal and pediatric intensive care units. Avanos Medical is a medical technology company focused on delivering clinically superior breakthrough medical device... Read More »
Keensight Capital Acquires Majority Stake in Isto Biologics
French private equity firm Keensight Capital announced it has agreed to acquire a majority stake in Isto Biologics from Thompson Street Capital Partners. Founded in 2016, Isto Biologics is a regenerative MedTech company developing and manufacturing orthobiologic products to help patients heal faster. Isto’s product offering covers six functional areas of unique bone graft solutions, and includes a range of allografts, which are notably used for bone repair in the spine. Isto sells its products to more than 400 hospitals and clinics, which are used in 15,000 surgical procedures per month, primarily in the United States. Keensight Capital is a European growth buyout firm. With more than 25... Read More »
Alcon to Acquire STAAR Surgical Company
According to an August 5 announcement, Alcon has entered into a definitive merger agreement to acquire STAAR Surgical Company. The transaction represents a total equity value of approximately $1.5 billion. STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures and sells implantable lenses for the eye and accessory delivery systems to deliver the lenses into the eye. According to its most recent annual report, STAAR generated $313.9 million in revenue during the fiscal year 2024 and had an EBITDA loss of $8 million. Alcon, a division of Novartis, researches and develops products for eye conditions such as cataracts, glaucoma, retinal diseases and refractive... Read More »
ArchiMed Acquires ZimVie for $730 Million
On July 21, ArchiMed announced that it purchased ZimVie for $730 million. ZimVie stockholders will receive $19 in cash for each share of ZimVie common stock outstanding at the closing of the transaction. ZimVie is a global life sciences leader in the dental market that develops, manufactures and delivers a comprehensive portfolio of products and solutions designed to support dental tooth replacement and restoration procedures. Zimvie spun out of Zimmer Biomet in 2022 and has since broken off into smaller pieces. ArchiMed is an independent private equity investment firm focused exclusively on the healthcare industry. It has directly managed and invested in more than... Read More »
PE-Backed TEAM Technologies Buys Duke Empirical
TEAM Technologies announced on July 7 its acquisition of Duke Empirical, Inc. TEAM Technologies is a portfolio company of Arlington Capital Partners, a Washington, D.C.-area private investment firm specializing in government-regulated industries. Based in Morgan Hill, California, Duke Empirical is a designer, developer and manufacturer of advanced medical devices for interventional cardiovascular applications. Duke specializes in catheters and minimally invasive delivery systems. Headquartered in Knoxville, Tennessee, with facilities throughout the United States, Mexico and Singapore, TEAM Technologies is a specialized end-to-end outsourced manufacturer of mission-critical,... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
